# US Polysomnography Devices Market > US Polysomnography Devices Market Research Report By Type (Fixed Polysomnography Devices, Portable Polysomnography Devices) and By Application (Hospitals, Diagnostic Laboratories, Homecare Settings, Others) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 4.9% - **2024:** $ 74.53 Million - **2025:** $ 78.18 Million - **2035:** $ 126.18 Million - **Key Players:** Philips (NL), ResMed (AU), Medtronic (IE), Natus Medical (US), Sleep Number (US), Fisher & Paykel Healthcare (NZ), Compumedics (AU), Neurovirtual (IT) **Report ID:** MRFR/HC/17402-HCR · **Pages:** 100 · **Author:** Nidhi Mandole & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-polysomnography-devices-market-18948 --- ## Market Summary ## **US Polysomnography Devices Market Overview** As per MRFR analysis, the US Polysomnography Devices Market Size was estimated at 70.07 (USD Million) in 2023. The US Polysomnography Devices Market Industry is expected to grow from 73.5(USD Million) in 2024 to 137 (USD Million) by 2035. The US Polysomnography Devices Market CAGR (growth rate) is expected to be around 5.824% during the forecast period (2025 - 2035). ### **Key US Polysomnography Devices Market Trends Highlighted** The US Polysomnography Devices Market is experiencing notable trends driven largely by an increasing awareness of sleep disorders and the importance of sleep health. There is a rising prevalence of conditions like sleep apnea, which has heightened the demand for effective diagnostic tools. Additionally, advancements in technology have led to the development of more sophisticated and user-friendly polysomnography devices. These innovations often include portable and home-based testing options, making it easier for patients to undergo sleep studies without the need for hospital visits. There are significant opportunities to be captured in telehealth integration and remote monitoring solutions, as more healthcare providers embrace digital health technologies. The US has been pushing for improved access to sleep disorder treatments through telemedicine, allowing for better patient reach and convenience, particularly in rural areas. This shift is accompanied by changes in insurance coverage policies, which are increasingly recognizing the importance of home sleep testing and monitoring solutions. Recent trends indicate a shift towards the use of artificial intelligence and data analytics in sleep study interpretation, offering more accurate diagnoses and personalized treatment plans. As more healthcare systems aim to enhance the patient experience, these technological advancements can play a key role in improving outcomes and operational efficiencies. Increased collaboration between sleep specialists, technology developers, and healthcare providers is shaping the market landscape, fostering innovation and ensuring that patients receive timely and effective care. This convergence of technology and healthcare is critical as the US seeks to address the growing public health challenge of sleep-related disorders. Source: Primary Research, Secondary Research, MRFR Database and Analyst Review ## **US Polysomnography Devices Market Drivers** ### **Increasing Prevalence of Sleep Disorders** The incidence of sleep disorders, particularly sleep apnea, is on the rise in the United States. According to the American Academy of Sleep Medicine, sleep apnea affects approximately 22 million Americans, which significantly drives the demand for polysomnography devices in the US Polysomnography Devices Market Industry. With the Centers for Disease Control and Prevention reporting that about 35% of American adults are not getting adequate sleep, the rising awareness of the health impacts of poor sleep quality has led to more patients seeking diagnostic solutions. Major players in the market, such as Philips and ResMed, are working continuously to innovate and improve their polysomnography devices to cater to this growing pool of patients. The necessity for effective sleep disorder management solutions propels market growth, as there is an increasing emphasis on diagnosing and treating such conditions. ### **Technological Advancements in Diagnostic Equipment** Technological innovations in the polysomnography devices segment are significantly enhancing the accuracy and reliability of sleep studies. Recently, there has been a surge in the use of portable and home-based polysomnography units due to advancements in sensor technologies and data analytics. The United States Food and Drug Administration (FDA) has been approving more portable devices that allow home sleep apnea testing, leading to increased accessibility for patients. This shift toward portable devices relates directly to consumer preferences for convenience and ease of use, driving adoption within the US [Polysomnography Devices Market](../../../reports/polysomnography-devices-market-11741) Industry. Manufacturers like Nox Medical and SleepScore Labs are developing cutting-edge technology that simplifies the sleep study process, aiming to meet the needs of a tech-savvy consumer base. ### **Growing Awareness and Acceptance of Sleep Health** Public health initiatives and campaigns aimed at raising awareness of sleep health have been gaining momentum across the United States. The National Sleep Foundation has been actively involved in educating the public about the consequences of untreated sleep disorders and the importance of sleep hygiene. Such awareness is fostering a culture of acceptance regarding sleep health issues, encouraging individuals to seek medical assistance when symptoms arise. This cultural shift is further supported by healthcare systems and insurance providers increasingly recognizing the necessity of effective sleep disorder treatment, which is positively influencing the growth of the US Polysomnography Devices Market Industry. The increase in healthcare coverage for sleep diagnostics also leads to more patients utilizing polysomnography services. ### **Rising Geriatric Population Struggling with Sleep Disorders** The demographic shift towards an aging population in the United States presents a significant driver for the US Polysomnography Devices Market. According to data from the U.S. Census Bureau, the number of individuals aged 65 and older is expected to double from 52 million in 2018 to over 95 million by 2060. This group is particularly susceptible to sleep disorders, including insomnia and sleep apnea, thus increasing the demand for polysomnography testing. As geriatric patients often have comorbidities that exacerbate sleep disorders, healthcare providers are urged to focus on comprehensive sleep assessment, leading to continued market expansion. Companies like Fisher & Paykel Healthcare are investing in more user-friendly devices that cater specifically to the older demographic's unique needs in the realm of polysomnography. ## **US Polysomnography Devices Market Segment Insights** ### **Polysomnography Devices Market Type Insights** The US Polysomnography Devices Market is an essential segment within the healthcare technology industry that focuses significantly on sleep disorders and their detection. This market is categorized into two primary types: Fixed Polysomnography Devices and Portable Polysomnography Devices. Fixed Polysomnography Devices are typically utilized in sleep laboratories and hospitals, providing comprehensive data about sleep patterns, including various physiological parameters. These devices often require patients to stay overnight in a controlled environment, allowing for an extensive evaluation of their sleep cycles. This type is essential for accurate diagnoses of complex sleep disorders such as sleep apnea, narcolepsy, and parasomnias, due to the depth of information they can gather. On the other hand, Portable Polysomnography Devices are becoming increasingly significant as they allow for flexibility and convenience, enabling patients to conduct sleep studies in the comfort of their own homes. These devices are often simpler, less expensive, and user-friendly, making them an attractive option for a growing number of patients. The adoption of home sleep testing has surged, particularly in response to the COVID-19 pandemic, which has heightened the focus on remote healthcare solutions. This shift not only empowers patients by providing access to testing without the need for hospital visits but also supports healthcare providers in managing resource allocation more efficiently. Both types of devices are crucial to the overall landscape of sleep medicine in the US, as they cater to different patient needs and healthcare settings. The growth of the US Polysomnography Devices Market is driven by growing awareness of sleep disorders and an increasing prevalence of conditions like obesity and diabetes, known contributors to sleep apnea. This is further supported by technological advancements that enhance the performance and accuracy of both fixed and portable devices, leading to improved patient outcomes. These trends, coupled with an aging population requiring more healthcare services, contribute positively to the future of the market. As stakeholders within the US healthcare sector recognize the value of early diagnosis and intervention through polysomnography, the demand for both Fixed and Portable Polysomnography Devices is expected to continue its upward trajectory. Source: Primary Research, Secondary Research, MRFR Database and Analyst Review ### **Polysomnography Devices Market Application Insights** The Application segment of the US Polysomnography Devices Market is critical in addressing sleep disorders among the population, focusing on varied settings such as Hospitals, Diagnostic Laboratories, Homecare Settings, and others. Hospitals play a vital role as they typically offer comprehensive care and access to specialists, leading to accurate diagnoses and treatment options. Diagnostic Laboratories are essential for conducting thorough sleep studies, ensuring precise data collection, which contributes to the growing demand for these devices. Homecare Settings are increasingly gaining significance as patients prefer the comfort of their homes for sleep testing, driven by technological advancements that facilitate remote monitoring. This trend has been bolstered by a rise in chronic sleep disorders, paving the way for innovative solutions. Moreover, the 'Others' category encompasses specialized facilities that cater to unique patient needs, indicating a versatile market landscape. The evolving patient-centric approach and increasing awareness regarding sleep health further support market growth, establishing the Application segment as a key player in enhancing sleep disorder management across the US. Through advancements in technology and patient care, there lies a substantial opportunity for the US Polysomnography Devices Market to expand significantly in the coming years. ## **US Polysomnography Devices Market Key Players and Competitive Insights** The US Polysomnography Devices Market is a highly specialized segment within the medical technology industry that focuses on sleep disorder diagnostics and monitoring. This market has gained traction due to the rising prevalence of sleep apnea and other related disorders, driving demand for advanced diagnostic tools and devices. Competitive insights reveal a landscape characterized by innovation, strategic partnerships, and an escalating emphasis on enhancing the quality of sleep diagnostics. Manufacturers are increasingly focusing on developing user-friendly and technologically advanced devices that incorporate features such as cloud connectivity, mobile applications, and real-time monitoring to provide efficient and accurate assessments for clinicians and patients alike. The market is also witnessing accelerated growth driven by regulatory approvals, heightened awareness among healthcare providers, and a growing demographic of aging patients who are more susceptible to sleep-related conditions. Ape Medical has established a strong foothold in the US Polysomnography Devices Market through its commitment to innovation and quality. The company specializes in providing state-of-the-art sleep diagnostic equipment, which is recognized for its reliability and ease of use. Ape Medical has developed a portfolio of products that cater to various sleep disorders, emphasizing accurate data capture and user comfort. Its strengths lie in its research and development efforts, which enable the company to stay ahead of industry trends and regulatory changes. The company enjoys a robust market presence bolstered by strategic collaborations with healthcare facilities and sleep centers across the US, positioning itself as a trusted partner in sleep diagnostics. CareFusion, known for its comprehensive range of medical devices and technology, has significantly influenced the US Polysomnography Devices Market. The company offers an array of polysomnography devices designed to enhance patient monitoring and diagnosis. CareFusion's products focus on providing precise measurements and facilitating better patient outcomes, which is critical in the sleep disorder diagnostics landscape. The company maintains a solid market presence through various strategic initiatives, including mergers and acquisitions that have expanded its technology portfolio and market reach. CareFusion’s ongoing commitment to research and development allows it to introduce cutting-edge technologies aimed at improving diagnostic accuracy and patient comfort. Additionally, its established relationships with healthcare providers reinforce its status as a key player in the US polysomnography market, offering innovative solutions that meet the growing demands of clinical sleep diagnostics. ### **Key Companies in the US Polysomnography Devices Market Include** ## **US Polysomnography Devices Market Industry Developments** Recent developments in the US Polysomnography Devices Market highlight a growing interest in sleep-related health technologies. Companies like ResMed and Philips Healthcare are leading product innovations, enhancing their offerings to improve patient outcomes and comfort. The increased prevalence of sleep disorders, as indicated by the National Institutes of Health, is raising demand for effective diagnostic and therapeutic devices. In September 2023, Compumedics announced a collaboration aimed at advancing research in sleep disorders, potentially expanding their market footprint. Additionally, in August 2023, Medtronic unveiled a new sleep monitor designed to offer home-based assessment, further tapping into the shift towards at-home diagnostics. Notable mergers include Fisher and Paykel Healthcare acquiring a smaller tech company in May 2023, aimed at boosting their capabilities in e-health technology for sleep apnea. Furthermore, in the last two years, the market has seen significant investment growth, with projections suggesting an increase in the market valuation driven by technological advancements and increasing awareness about sleep health. Regulatory developments from the Food and Drug Administration are also shaping the landscape, influencing how devices are tested and brought to market for consumer use. ## **US Polysomnography Devices Market Segmentation Insights** ### **Polysomnography Devices Market Type Outlook** ### **Polysomnography Devices Market Application Outlook** ## Market Drivers ### Increased Healthcare Expenditure The upward trend in healthcare expenditure in the United States is positively influencing the polysomnography devices market. With healthcare spending projected to reach $6 trillion by 2027, there is a growing allocation of funds towards advanced diagnostic technologies. This financial commitment enables healthcare facilities to invest in state-of-the-art polysomnography devices, enhancing their diagnostic capabilities. Furthermore, increased reimbursement rates for sleep studies by insurance providers encourage more healthcare practitioners to utilize these devices. As a result, the polysomnography devices market is likely to expand, driven by the need for improved diagnostic accuracy and patient care. ### Growing Awareness of Sleep Health There is a notable increase in public awareness regarding the importance of sleep health, which is significantly impacting the polysomnography devices market. Campaigns promoting the understanding of sleep disorders and their effects on overall health have led to more individuals seeking medical advice. This heightened awareness is driving demand for polysomnography devices, as patients are more inclined to undergo sleep studies for accurate diagnosis. Additionally, healthcare professionals are emphasizing the need for proper sleep assessments, further propelling the market. The polysomnography devices market is thus positioned for growth as more individuals recognize the critical role of sleep in maintaining health. ### Rising Prevalence of Sleep Disorders The increasing incidence of sleep disorders, such as sleep apnea, insomnia, and restless leg syndrome, is a primary driver for the polysomnography devices market. According to recent estimates, approximately 22 million Americans suffer from sleep apnea alone, highlighting a significant demand for effective diagnostic tools. This growing prevalence necessitates advanced polysomnography devices to facilitate accurate diagnosis and treatment. As awareness of sleep disorders rises, healthcare providers are increasingly adopting these devices to improve patient outcomes. The polysomnography devices market is expected to experience substantial growth as more individuals seek diagnosis and treatment options, thereby driving innovation and investment in this sector. ### Technological Integration in Healthcare The integration of advanced technologies, such as artificial intelligence and telemedicine, into healthcare is transforming the polysomnography devices market. These innovations enhance the functionality and efficiency of polysomnography devices, allowing for remote monitoring and data analysis. For instance, AI algorithms can analyze sleep patterns more accurately, leading to better diagnostic outcomes. The adoption of telemedicine facilitates access to sleep studies, particularly for patients in remote areas. As healthcare systems increasingly embrace these technologies, the polysomnography devices market is likely to witness significant advancements, improving patient care and operational efficiency. ### Regulatory Support for Sleep Disorder Treatments Regulatory bodies in the United States are increasingly supporting the development and approval of devices for sleep disorder treatments, which is beneficial for the polysomnography devices market. Initiatives aimed at expediting the approval process for innovative diagnostic tools encourage manufacturers to invest in research and development. This regulatory support not only fosters innovation but also ensures that patients have access to the latest technologies for sleep assessment. As a result, the polysomnography devices market is expected to grow, driven by a favorable regulatory environment that promotes the introduction of advanced diagnostic solutions. ## Future Outlook The [Polysomnography Devices Market](https://www.marketresearchfuture.com/reports/polysomnography-devices-market-11741) is projected to grow at a 4.9% CAGR from 2025 to 2035, driven by increasing sleep disorders and technological advancements. **New opportunities:** - Development of portable polysomnography devices for home use. - Integration of AI for enhanced sleep analysis and reporting. - Expansion into telehealth services for remote patient monitoring. By 2035, the market is expected to achieve substantial growth, driven by innovation and increased demand. ## Segment Insights ### By Type: Fixed Polysomnography Devices (Largest) vs. Portable Polysomnography Devices (Fastest-Growing) In the US polysomnography devices market, Fixed Polysomnography Devices account for the largest market share, driven by their reliability and advanced technology integration in healthcare settings. Their ability to provide comprehensive data and real-time monitoring establishes them as the preferred choice among healthcare professionals. In contrast, Portable Polysomnography Devices have gained significant traction, appealing to patients seeking convenience and flexibility, subsequently carving a notable share in the market. The growth trends for the segment are influenced by increasing sleep disorder diagnoses and rising patient awareness towards sleep health. Portable devices, in particular, are experiencing rapid growth due to technological advancements enhancing their accuracy and usability. This segment is further propelled by a growing need for at-home sleep testing solutions, as patients prefer the comfort of their own homes for monitoring sleep apnea and related disorders, driving manufacturer innovation and competition. Polysomnography Devices: Fixed (Dominant) vs. Portable (Emerging) Fixed Polysomnography Devices are established as the dominant players in the US polysomnography devices market due to their comprehensive capabilities and robustness within clinical settings. They are predominantly used in hospitals and sleep centers, providing extensive data for diagnoses. Their advanced technology often integrates with hospital networks, allowing for thorough patient management. On the other hand, Portable Polysomnography Devices are emerging as a significant alternative, particularly for patients seeking to conduct sleep studies at home. This flexibility appeals to a wide demographic, making them increasingly popular. As the healthcare landscape evolves, these portable devices are being designed to offer comparable accuracy to traditional fixed devices while promoting greater accessibility and convenience for users. ### By Application: Hospitals (Largest) vs. Homecare Settings (Fastest-Growing) In the US polysomnography devices market, hospitals hold the largest share due to their advanced diagnostic capabilities and comprehensive patient care facilities. The integration of sleep studies into hospital services has solidified their position as the primary choice for polysomnography. Conversely, homecare settings are gaining traction, capturing a significant portion of the market as patients increasingly prefer the comfort and convenience of at-home testing. The growth in the US polysomnography devices market is driven primarily by the rising prevalence of sleep disorders and an increasing awareness of sleep health. Homecare settings are particularly notable as they represent the fastest-growing segment. This growth is facilitated by technological advancements in portable devices and telehealth services that enable efficient remote monitoring and diagnosis, catering to the shifting preferences of patients who opt for home-based care alternatives. Hospitals (Dominant) vs. Homecare Settings (Emerging) Hospitals dominate the US polysomnography devices market by providing comprehensive diagnostic services and specialized medical attention. Equipped with the latest technology and skilled personnel, they offer a high-quality care experience, attracting a significant patient base. In contrast, homecare settings are emerging as a viable alternative, capitalizing on the demand for minimally invasive and patient-friendly solutions. These settings leverage portable monitoring devices that allow for flexible testing environments, thus appealing to patients seeking convenience. The dual presence of hospitals and homecare solutions addresses diverse patient needs, positioning them strategically in the evolving landscape of sleep disorder diagnostics. ## Competitive Benchmarking The polysomnography devices market is characterized by a dynamic competitive landscape, driven by increasing awareness of sleep disorders and the growing demand for effective diagnostic tools. Key players such as Philips (NL), ResMed (AU), and Natus Medical (US) are at the forefront, each adopting distinct strategies to enhance their market presence. Philips (NL) emphasizes innovation through advanced technology integration, focusing on digital health solutions that facilitate remote monitoring and patient engagement. ResMed (AU) has positioned itself as a leader in cloud-connected devices, leveraging data analytics to improve patient outcomes. Meanwhile, Natus Medical (US) concentrates on expanding its product portfolio and enhancing its service capabilities, thereby strengthening its competitive edge in the market.The business tactics employed by these companies reflect a concerted effort to optimize operations and adapt to market demands. Localizing manufacturing and optimizing supply chains are prevalent strategies aimed at reducing costs and improving responsiveness. The market structure appears moderately fragmented, with several players vying for market share, yet the influence of major companies remains substantial, shaping the overall competitive dynamics. In October Philips (NL) announced the launch of a new line of sleep diagnostic devices that incorporate artificial intelligence to enhance accuracy in sleep apnea detection. This strategic move not only reinforces Philips' commitment to innovation but also positions the company to capture a larger share of the growing demand for advanced sleep solutions. The integration of AI is likely to set a new standard in the industry, compelling competitors to elevate their technological offerings. In September ResMed (AU) expanded its partnership with a leading telehealth provider to enhance remote patient monitoring capabilities. This collaboration is significant as it aligns with the increasing trend towards digital health solutions, allowing ResMed to offer comprehensive care pathways for patients with sleep disorders. Such strategic alliances may enhance patient engagement and adherence to treatment, ultimately driving better health outcomes. In August Natus Medical (US) acquired a smaller firm specializing in sleep diagnostic software, thereby broadening its technological capabilities. This acquisition is indicative of Natus Medical's strategy to enhance its product offerings and integrate advanced software solutions into its existing devices. By doing so, the company aims to provide a more holistic approach to sleep diagnostics, which could potentially lead to increased market penetration. As of November the competitive trends in the polysomnography devices market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in enhancing their technological capabilities and market reach. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition towards a focus on innovation, advanced technology, and supply chain reliability. This shift suggests that companies that prioritize research and development, alongside strategic partnerships, will be better positioned to thrive in an increasingly competitive environment. ## Recent News & Developments Recent developments in the US Polysomnography Devices Market highlight a growing interest in sleep-related health technologies. Companies like ResMed and Philips Healthcare are leading product innovations, enhancing their offerings to improve patient outcomes and comfort. The increased prevalence of sleep disorders, as indicated by the National Institutes of Health, is raising demand for effective diagnostic and therapeutic devices. In September 2023, Compumedics announced a collaboration aimed at advancing research in sleep disorders, potentially expanding their market footprint. Additionally, in August 2023, Medtronic unveiled a new sleep monitor designed to offer home-based assessment, further tapping into the shift towards at-home diagnostics. Notable mergers include Fisher and Paykel Healthcare acquiring a smaller tech company in May 2023, aimed at boosting their capabilities in e-health technology for sleep apnea. Furthermore, in the last two years, the market has seen significant investment growth, with projections suggesting an increase in the market valuation driven by technological advancements and increasing awareness about sleep health. Regulatory developments from the Food and Drug Administration are also shaping the landscape, influencing how devices are tested and brought to market for consumer use. ## Report Scope | MARKET SIZE 2024 | 74.53(USD Million) | | --- | --- | | MARKET SIZE 2025 | 78.18(USD Million) | | MARKET SIZE 2035 | 126.18(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.9% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Philips (NL), ResMed (AU), Medtronic (IE), Natus Medical (US), Sleep Number (US), Fisher & Paykel Healthcare (NZ), Compumedics (AU), Neurovirtual (IT) | | Segments Covered | Type, Application | | Key Market Opportunities | Integration of artificial intelligence in polysomnography devices enhances diagnostic accuracy and patient outcomes. | | Key Market Dynamics | Technological advancements and regulatory changes drive innovation in the polysomnography devices market. | | Countries Covered | US | ## Frequently Asked Questions **Q: What was the market valuation of polysomnography devices in 2024?** A: The market valuation of polysomnography devices was 74.53 USD Million in 2024. **Q: What is the projected market valuation for polysomnography devices by 2035?** A: The projected market valuation for polysomnography devices is 126.18 USD Million by 2035. **Q: What is the expected CAGR for the US polysomnography devices market during 2025 - 2035?** A: The expected CAGR for the US polysomnography devices market during 2025 - 2035 is 4.9%. **Q: Which companies are considered key players in the polysomnography devices market?** A: Key players in the polysomnography devices market include Philips, ResMed, Medtronic, Natus Medical, Sleep Number, Fisher & Paykel Healthcare, Compumedics, and Neurovirtual. **Q: What are the two main types of polysomnography devices and their market values?** A: The two main types of polysomnography devices are Fixed Polysomnography Devices valued at 30.0 - 50.0 USD Million and Portable Polysomnography Devices valued at 44.53 - 76.18 USD Million. **Q: How do hospitals and diagnostic laboratories compare in terms of market valuation for polysomnography devices?** A: Hospitals have a market valuation of 30.0 - 50.0 USD Million, while diagnostic laboratories range from 20.0 - 35.0 USD Million. **Q: What is the market valuation range for polysomnography devices in homecare settings?** A: The market valuation for polysomnography devices in homecare settings ranges from 15.0 - 30.0 USD Million. **Q: What is the market valuation for other applications of polysomnography devices?** A: The market valuation for other applications of polysomnography devices is between 9.53 - 11.18 USD Million. **Q: How does the market for portable polysomnography devices compare to fixed devices?** A: The market for portable polysomnography devices, valued at 44.53 - 76.18 USD Million, appears to be larger than that for fixed devices, which is valued at 30.0 - 50.0 USD Million. **Q: What trends are anticipated in the polysomnography devices market by 2035?** A: Trends suggest that the polysomnography devices market will continue to grow, reaching a projected valuation of 126.18 USD Million by 2035. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-polysomnography-devices-market-18948*